Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 35, 2022 - Issue 25
Submit an article Journal homepage
553
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

NAFTNet retrospective report on the treatment of anti-Ro/SSA mediated fetal heart block with dexamethasone

Sherzana Sunderjia Department of Pediatrics, University of California, Davis, Sacramento, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5335-3481View further author information
ORCID Icon,
Shabnam Peyvandib Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USAView further author information
,
Edgar Jaeggic The Hospital for Sick Children, Toronto, CanadaView further author information
,
Anita Szwastd The Children’s Hospital of Philadelphia, Philadelphia, PA, USAView further author information
,
Greg Ryane Mount Sinai Hospital, Toronto, CanadaView further author information
,
Francine Tessierf Children’s & Women’s Health Centre of British Columbia, Vancouver, CanadaView further author information
,
Saad Siddiquig Advocate Children’s Hospital, Oak Lawn, IL, USAView further author information
,
Bettina Cuneoh Children’s Hospital of Colorado, Aurora, CO, USAView further author information
,
Shreya Shethi Texas Children’s Hospital, Houston, TX, USAView further author information
,
Marjorie Treadwellj Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USAView further author information
,
Michele Frommeltk Children’s Hospital of Wisconsin, Milwaukee, WI, USAView further author information
,
Shifa Turanl Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD, USAView further author information
,
Joshua Copelm Yale School of Medicine, New Haven, CT, USAView further author information
,
Stephen Emeryn Department of Obstetrics, Gynecology, & Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAView further author information
,
Larry Randb Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USAView further author information
,
Anita J. Moon-Gradyb Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USAView further author information
& for the North American Fetal Therapy Network (NAFTNet) show all
Pages 9263-9270 | Received 27 Sep 2021, Accepted 31 Dec 2021, Published online: 11 Jan 2022

References

  • Brucato A, Doria A, Frassi M, et al. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus. 2002;11(11):716–721.
  • Tsuboi H, Sumida T, Noma H, et al. Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-a antibodies. Mod Rheumatol. 2016;26(4):569–575.
  • Izmirly PM, Saxena A, Kim MY, et al. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation. 2011;124(18):1927–1935.
  • Askanase AD, Friedman DM, Copel J, et al. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies. Lupus. 2002;11(3):145–151.
  • Eliasson H, Sonesson SE, Sharland G, et al. Isolated atrioventricular block in the fetus: a retrospective, multinational, multi-center study of 175 patients. Circulation. 2011;124(18):1919–1926.
  • Saleeb S, Copel J, Friedman D, et al. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the Research Registry for Neonatal Lupus. Arthritis Rheum. 1999;42(11):2335–2345.
  • Saxena A, Izmirly P, Mendez B, et al. Prevention and treatment in utero of autoimmune-associated congenital heart block. Cardiol Rev. 2014;22(6):263–267.
  • Donofrio MT, Moon-Grady AJ, Hornberger LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129(21):2183–2242.
  • Jaeggi ET, Fouron JC, Silverman ED, et al. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation. 2004;110(12):1542–1548.
  • Izmirly PM, Saxena A, Sahl SK, et al. Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system. Ann Rheum Dis. 2016;75(6):1161–1165.
  • Glickstein JS, Buyon JP, Friedman D. The fetal PR interval: pulsed Doppler echocardiographic assessment of the fetal PR interval. Am J Cardiol. 2000;86(2):236–239.
  • Rosenthal D, Friedman DM, Buyon J, et al. Validation of the Doppler PR interval in the fetus. J Am Soc Echocardiogr. 2002;15(9):1029–1030.
  • Nii M, Hamilton RM, Fenwick L, et al. Assessment of fetal atrioventricular time intervals by tissue Doppler and pulse Doppler echocardiography: normal values and correlation with fetal electrocardiography. Heart. 2006;92(12):1831–1837.
  • Horsfall AV, Venables PJW, Taylor PV, et al. Ro and La antigens and maternal anti-La idiotype on the surface of myocardial fibres in congenital heart block. J Autoimmun. 1991;4(1):165–176.
  • Reichlin M, Brucato A, Frank MB, et al. Concentration of autoantibodies to native 60-kd Ro/SS-a and denatured 52-kd Ro/SS-a in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum. 1994;37(11):1698–1703.
  • Litsey SE, Noonan JA, O'Connor WN, et al. Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue. N Engl J Med. 1985;312(2):98–100.
  • Lee LA, Coulter S, Erner S, et al. Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti-Ro autoantibodies. Am J Med. 1987;83(4):793–796.
  • Cuneo BF, Lee M, Roberson D, et al. A management strategy for fetal immune-mediated atrioventricular block. J Matern Fetal Neonatal Med. 2010;23(12):1400–1405.
  • Skog A, Wahren-Herlenius M, Sundstrom B, et al. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies. Pediatrics. 2008;121(4):e803–e809.
  • Martínez-Sánchez N, Pérez-Pinto S, Robles-Marhuenda Á, et al. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study. Immunol Res. 2017;65(2):487–494.
  • Friedman DM, Kim MY, Copel JA, et al. Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) study. Am J Cardiol. 2009;103(8):1102–1106.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.